Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy

Digestive Diseases and Sciences

Volumn 48, Issue 1, 2003, Pages 36-46

  Konturek, Peter C ^a   Rembiasz, Kazimierz ^b   Konturek, Stanislaw J ^b   Stachura, Jerzy ^b   Bielanski, Wladyslaw ^b   Galuschka, K ^a   Karcz, Danuta ^b   Hahn, Eckhart G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Atrophic gastritis; COX 2; Gastrin; Helicobacter pylori; Ornithine decarboxylase

Indexed keywords

AMOXICILLIN; ASCORBIC ACID; CAGA PROTEIN; CARBON 13; CLARITHROMYCIN; CYCLOOXYGENASE 2; GASTRIN; IMMUNOGLOBULIN G ANTIBODY; OMEPRAZOLE; ORNITHINE DECARBOXYLASE;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BACTERIAL STRAIN; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; GASTRIN BLOOD LEVEL; GENE EXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH CANCER; STOMACH MUCOSA; STOMACH SECRETION; TREATMENT OUTCOME; UPREGULATION; UREA BREATH TEST;

AMOXICILLIN; ANTI-ULCER AGENTS; CLARITHROMYCIN; CYCLOOXYGENASE 2; DRUG THERAPY, COMBINATION; FEMALE; GASTRIC MUCOSA; GASTRINS; GASTRITIS, ATROPHIC; GENE EXPRESSION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OMEPRAZOLE; ORNITHINE DECARBOXYLASE; PEROXIDASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 0037280476     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021774029089     Document Type: Article

References (37)

1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311-1315, 1984
2. Peterson WL: Helicobacter pylori and peptic ulcer disease. N Engl J Med 324:1043-1048, 1991
3. Huang JQ, Sridhar S, Chen Y, Hunt RH: Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroneterology 114:1169-1179, 1999
4. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori and the development of gastric cancer. N Engl J Med 345:784-789, 2001
5. Stolte M: H. pylori and gastric MALT lymphoma. Lancet 339:745-746, 1992
6. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process - First American Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735-6740, 1992
7. Kuipers EJ, Grool TA: The dynamics of gastritis. Curr Gastroenterol Rep 3:509-515, 2001
8. Heby O: Role of polyamines in the control of cell proliferation and differentiation. Differentiation 9:1-20, 1981
9. Patchett SE, Alstead EM, Butruk L, Przytulski K, Farthing MJ: Ornithine decarboxylase as a marker for premalignancy in the stomach. Gut 37:13-16, 1995
10. Patchett SE, Katelaris PH, Zhang ZW, Alstead EM, Domizio P, Farthing MJ: Ornithine decarboxylase activity is a marker of premalignany in longstanding Helicobactr pylori infection. Gut 39:807-810, 1996
11. Hirasawa R, Tatsuta M, Iishi H, Yano H, Baba M, Uedo N, Sakai N: Increase in apoptosis and decrease in ornithine decarboxylase activity of the gastric mucosa in patients with atrophic gastritis and gastric ulcer after successful eradication of Helicobacter pylori. Am J Gastroenterol 94:2398-2402, 1999
12. Wang TC, Daugler CA, Chen D, Goldenring JR, Koh T, Raychowdhurry R, Coffey RJ, Ito S, Varro A, Dockray GJ, Fox JG: Synergistic interaction between hypergastrinemia and Helicobacter infection in mouse model of gastric cancer. Gastroenterology 118:36-41, 2000
13. Van Rees BP, Ristimäki BP: Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract. Scand J Gastroenterol 9:897-901, 2001
14. Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, Chan FK: Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 157:729-735, 2000
15. Dixon MF, Genta RM, Yardley JH: Classification and grading of gastritis. The Updated Sydney System. Am J Surg Pathol 20:1161-1181, 1996
16. Konturek PC, Konturek SJ, Sulekova Z, Meixner H, Bielanski W, Starzynska T, Karczewska E, Marlicz K, Stachura J, Hahn EG: Expression of hepatocyte growth factor, transforming growth factor alpha, apoptosis related proteins Bax and Bcl-2, and gastrin in human gastric cancer. Aliment Pharmacol Ther 15:989-999, 2001
17. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
18. Konturek JW, Gutwinska-Konturek M, Gabrylewicz A, Konturek SJ, Domschke W: Cholecystokinin in the control of gastric acid secretion in humans. J Clin Gastroenterol 19 (suppl 1):S40-S45, 1993
19. Konturek PC, Bielanski W, Konturek SJ, Hartwich A, Rehfeld JF: Progastrin and cyclooxygenases-2 in colorectal cancer. Dig Dis Sci (in press)
20. 13C-urea in the diadnosis of Helicobacter pylori infection. J Physiol Pharmacol 47:545-553, 1996
21. Konturek JW, Bielanski W, Konturek SJ: Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients. J Physiol Pharmacol 47:161-176, 1996
22. Sung JJ, Lin SR, Ching JY, Zhou LY, To KF, Wang RT, Leung WK, Ng EK, Lau JY, Lee YT, Yeung CK, Chao W, Chung SC: Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroneterology 119:7-14, 2000
23. Ohkusa T, Fujiki K, Takashimizu I, Kumagai J, Tanizawa T, Eishi Y, Yokoyama T, Watanabe M: Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 134:380-386, 2001
24. Annibale B, Aprile MR, D'ambra G, Caruna P, Bordi C, Delle Fave G: Cure of H. pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 14:625-634, 2000
25. Satoh K, Kimura K, Takimoto T, Kihira K: A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 3:236-240, 1998
26. Auvinen M, Paasinen A, Anderson LC, Höltta E: Ornithine decarboxylase activity is critical for cell transformation. Nature 360:355-358, 1992
27. Alam K, Arlow FL, Ma CK, Schubert TT: Decrease in ornithine decarboxylase activity after eradication of Helicobacter pylori. Am J Gastroenterol 89:888-893, 1994
28. Russo F, Linsalata M, Giorgio I, Caruso ML, Armentano R, Di Leo A: Polyamine levels and ODC activity in intestinal-type and diffuse-type gastric carcinoma. Dig Dis Sci 42:576-579, 1997
29. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y: Helicobacter pylori in intestinal- and diffuse-type gastric adenocarcinoma. J Natl Cancer Inst 83:640-643, 2002
30. Humar B, D'Orazio D, Albrecht C, Bauerfeind P, Muller H, Dobbie Z, Bendik I: Expression of putative anticancer targets in familial adenomatous polyposis and its association with the APC mutation status. Int J Oncol 19:1179-1186, 2001
31. Ristimäki A, Honkanen N, Jänkälä H, Sipponen P, Härkönen M: Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57:1276-1280, 2002
32. Tsuji S, Tsujii M, Kawano S, Hori M: Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis. J Exp Clin Cancer Res 20:117-129, 2001
33. Takahashi S, Fujita T, Yamamoto A: Role of cyclooxygenase-2 in Helicobacter pylori-induced gastritis in Mongolian gerbils. Am J Gastrointest Liver Physiol 279:G791-G798, 2000
34. McColl KE, El-Omar E, Gillen D: Helicobacter pylori gastritis and gastric physiology. Gastroenterol Clin North Am 29:687-703, 2000
35. El-Omar EM: The importance of interleukin 1β in Helicobacter pylori associated disease. Gut 48:743-747, 2001
36. Bukin YV, Draudin-Krylenko VA, Orlov EN, Kuvshinov YP, Paddubny BK, Vorobyeva OV, Shabanov MA. Effect of prolong beta-carotene or DL-alpha-tocopheryl acetate supplementation on ornithine decarboxylase activity in human atrophic stomach mucosa. Cancer Epidemiol Biomarkers Prev 8:865-870, 1995.
37. Konturek SJ, Konturek PC, Plonka M, Duda A, Sito E, Zuchowicz M, Hahn EG: Implication of gastrin in cyclooxygenase expression in Helicobacter pylori-infected gastric ulceration. Prostaglandins Other Lipid Mediators 66:39-51, 2001